Clinical utility of complexed PSA.

被引：0
|
作者：
Sokoll, LJ
Cox, JL
Bruzek, DJ
Partin, AW
Morris, DL
Yeung, KK
Allard, W
Chan, DW
机构：
[1] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21205 USA
[2] Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21205 USA
[3] Bayer Corp, Tarrytown, NY USA
来源：
CLINICAL CHEMISTRY | 1998年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
205
引用
收藏
页码：A46 / A46
页数：1
相关论文
共 50 条
  • [11] Multicenter evaluation of the performance and clinical utility in longitudinal monitoring of the Bayer Immuno 1™ complexed PSA assay
    Allard, WJ
    Cheli, CD
    Morris, DL
    Goldblatt, J
    Pierre, Y
    Kish, L
    Chen, Y
    Dai, J
    Vessella, RL
    Chan, DW
    Schwartz, MK
    Zhou, Z
    Yeung, KK
    INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, 1999, 14 (02): : 73 - 83
  • [12] Prostate cancer: Genetic differences in PSA.
    Payton S.
    Nature Reviews Urology, 2014, 11 (3) : 130 - 130
  • [13] Clinical utility of total, free and complexed-PSA in the diagnosis of prostate carcinoma and benign prostate hyperplasia.
    Gaspar, MI
    Angulo, J
    Arribas, I
    Coca, MC
    CLINICAL CHEMISTRY, 1999, 45 (06) : A106 - A106
  • [14] NEW BIOLOGIC AND TARGETED SYNTHETIC DMARDS FOR THE TREATMENT OF PSA. HOW ARE THEY POSITIONED IN CLINICAL PRACTICE?
    Martins, P.
    Nero, P.
    Lopes, Pestana J.
    Silva, I.
    Teixeira, R. L.
    Fonseca, J. E.
    Santos, M. J.
    Vieira-Sousa, Elsa
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2021, 39 (05) : 1216 - 1217
  • [15] Alpha-1 antichymotrypsin complexed PSA in men under-going prostate biopsy offers significant advantage for the detection of carcinoma over total PSA and free-to-total PSA.
    Meyer, GE
    Brawer, MK
    Letran, JL
    Ransom, SD
    JOURNAL OF UROLOGY, 1998, 159 (05): : 72 - 72
  • [16] An assessment of serum PSA density with respect to different molecular forms and ratios of PSA.
    Mutch, WJ
    Croal, BL
    Mitchell, ID
    Dickie, A
    Cohen, N
    Ross, IS
    CLINICAL CHEMISTRY, 2001, 47 (06) : A132 - A133
  • [17] Complexed PSA: The newest advance in PSA testing
    Brawer, MK
    UROLOGY, 1999, 54 (01) : 2 - 3
  • [18] Complexed PSA (cPSA) has clinical utility in the early detection of prostatic carcinoma in men with total PSA values less than 4.0 ng/mL.
    Cheli, CD
    Yeung, KK
    Brawer, MK
    Allard, WJ
    CLINICAL CHEMISTRY, 1999, 45 (06) : A107 - A107
  • [19] Detection of prostate cancer with complexed PSA and complexed/total PSA ratio - is there any advantage?
    F. Strittmatter
    P. Stieber
    D. Nagel
    C. Füllhase
    S. Walther
    C. G. Stief
    R. Waidelich
    European Journal of Medical Research, 16
  • [20] DETECTION OF PROSTATE CANCER WITH COMPLEXED PSA AND COMPLEXED/TOTAL PSA RATIO - IS THERE ANY ADVANTAGE?
    Strittmatter, F.
    Stieber, P.
    Nagel, D.
    Fuellhase, C.
    Walther, S.
    Stief, C. G.
    Waidelich, R.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2011, 16 (10) : 445 - 450
12345